For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. IPO dates below are expected but not confirmed.
Alector, Inc. (ALEC) will issue 9.25 million shares between $18 and $20 Thursday on the Nasdaq. The San Francisco biotech develops therapies for Alzheimer’s Disease and Frontotemporal Dementia.
Gossamer Bio, Inc. (GOSS) will issue 14.375 million shares at $16 Friday on the Nasdaq. Based in San Diego, the pharmaceutical company develops treatments in the fields of immunology, inflammation, immuno-oncology and fibrosis.
Harpoon Therapeutics, Inc. (HARP) will issue 5.4 million shares between $13 and $15 Friday on the Nasdaq. The firm’s immuno-oncology pipeline uses T-cells to target prostate, ovarian and small-cell lung cancer, as well as multiple myeloma.
Monocle Acquisition (MNCLU) will issue 15 million shares at $10 Thursday on the Nasdaq. The blank-check company will target financially businesses in the aerospace and defense, industrial, technology and telecom industries.
Related Links:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.